Anti-CD20 monoclonal antibody (rituximab) in the treatment of autoimmune diseases. Successful result in refractory Pemphigus vulgaris: report of a case.
Virgolini
Luigi
L
Dipartimento di Medicina, U.O. Medicina 2, Azienda Ospedaliera Santa Maria degli Angeli, 33170 Pordenone, Italy. luigi.virgolini@aopn.fvg.it
Marzocchi
Vanda
V
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20 / Q000276:immunology; D005260:Female; D006801:Humans; D008875:Middle Aged; D010392:Pemphigus / Q000473:pathology / Q000628:therapy*; D000069283:Rituximab; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D000069283:Rituximab